Discontinuation report CEFTRIAXONE SODIUM FOR INJECTION BP
| Report ID | 274173 |
| Drug Identification Number | 02325594 |
| Brand name | CEFTRIAXONE SODIUM FOR INJECTION BP |
| Common or Proper name | CEFTRIAXONE SODIUM FOR INJECTION BP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 VIALS |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2026-05-31 |
| Remaining supply date | 2027-07-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Current inventory expires in July 2027. We anticipate to deplete our stock by May 2026. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-11 | French | Compare |
| v1 | 2025-12-11 | English | Compare |
Showing 1 to 2 of 2